Participants 55 159 3
intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction
Participants 177 373 3
value of routine administration of intravenous thrombolytic agents during percutaneous transluminal coronary angioplasty (PTCA) therapy of acute myocardial infarction (MI) has not been determined.
Participants 385 520 8
we prospectively randomized 122 patients with evolving MI to PTCA therapy with or without adjunctive intravenous streptokinase therapy.
Participants 541 723 5
Patients with ECG ST segment elevation who presented within 4 hours of symptom onset, had no contraindication to thrombolytic therapy, and were not in cardiogenic shock were enrolled
Participants 735 935 3
treated immediately with intravenous heparin (10,000 units) and oral aspirin (325 mg) and randomized to treatment with placebo or streptokinase (1.5 M units) administered intravenously over 30 minutes
Participants 1188 1234 5
A total of 106 patients were treated with PTCA
